Tectonic Therapeutic, Inc. (TECX)

20.66 +0.01 (+0.05%) USD  |  NASDAQ  |  Oct 19, 14:45
More

Tectonic Therapeutic Net Income (Quarterly) : -22.28M for June 30, 2026

Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -22.28M
March 31, 2026 -25.24M
December 31, 2025 -19.23M
September 30, 2025 -19.04M
June 30, 2025 -19.98M
March 31, 2025 -15.91M
December 31, 2024 -12.37M
September 30, 2024 -17.72M
June 30, 2024 -12.67M
March 31, 2024 -15.22M
December 31, 2023 -7.869M
September 30, 2023 -10.05M
June 30, 2023 -10.46M
March 31, 2023 -24.96M
December 31, 2022 -25.03M
September 30, 2022 -22.97M
June 30, 2022 -28.05M
March 31, 2022 -29.83M
December 31, 2021 -28.23M
Date Value
September 30, 2021 -32.61M
June 30, 2021 -31.39M
March 31, 2021 -26.90M
December 31, 2020 -28.13M
September 30, 2020 -36.78M
June 30, 2020 -28.83M
March 31, 2020 -25.97M
December 31, 2019 -22.66M
September 30, 2019 -17.14M
June 30, 2019 -16.06M
March 31, 2019 -17.10M
December 31, 2018 -16.02M
September 30, 2018 -11.59M
June 30, 2018 -10.51M
March 31, 2018 -8.242M
December 31, 2017 -7.596M
September 30, 2017 -6.441M
June 30, 2017 -2.534M
March 31, 2017 -2.077M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 31.50M
Alnylam Pharmaceuticals, Inc. 164.49M
Anika Therapeutics, Inc. 3.309M
Savara, Inc. -40.23M
Vericel Corp. 2.206M

Net Income (Quarterly) Related Metrics

Total Expenses (Quarterly) 22.28M
EPS Diluted (Quarterly) -1.175
Enterprise Value 174.54M
Earnings Yield -22.09%
Normalized Earnings Yield -22.09